Is the association between duration of untreated psychosis and outcome confounded? A two year follow-up study of first-admitted patients

Schizophrenia Research

Volumn 49, Issue 3, 2001, Pages 231-241

  Verdoux, Hélène ^a,b   Liraud, Florence ^a,b   Bergey, Chantal ^b   Assens, François ^b   Abalan, François ^b   Van Os, Jim ^c  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b CENTRE HOSPITALIER CHARLES PERRENS   (France)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Confounding factors; Duration of untreated psychosis; Outcome; Premorbid functioning

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; NEGATIVE SYNDROME; PRIORITY JOURNAL; PROGNOSIS; PSYCHOSIS; PSYCHOTHERAPY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTIPSYCHOTIC AGENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 0035971503     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(00)00072-4     Document Type: Article

References (32)

1. DSM-III-R. Diagnostic and Statistical Manual of Mental Disorders. third ed. revised :1987;American Psychiatric Association, Washington, DC.
2. DSM-IV. Diagnostic and Statistical Manual of Mental Disorders. fourth ed. 1994;American Psychiatric Association, Washington, DC.
3. Beiser M., Erickson D., Fleming J.A.E., Iacono W.G. Establishing the onset of psychotic illness. Am. J. Psychiatry. 150:1993;1349-1354.
4. Carbone S., Harrigan S., McGorry P.D., Elkins K. Duration of untreated psychosis and 12 month outcome in first-episode psychosis: the impact of treatment approach. Acta Psychiatr. Scand. 100:1999;96-104.
5. Craig T.J., Bromet E.J., Fennig S., Tanenberg-Karant M., Lavelle J., Galambos N. Is there an association between duration of untreated psychosis and 24 month clinical outcome in a first-admission series? Am. J. Psychiatry. 157:2000;60-66.
6. Crow T.J., McMillan J.F., Johnson A.L., Johnstone E.C. A randomised controlled trial of prophylactic neuroleptic treatment. Br. J. Psychiatry. 148:1986;120-127.
7. Edwards J., Maude D., McGorry P.D., Harrigan S.M., Coks J.T. Prolonged recovery in first-episode psychosis. Br. J. Psychiatry. 172:(Suppl. 33):1998;107-116.
8. Endicott J., Andreasen N., Spitzer R.L. Family History-Research Diagnostic Criteria. third ed. 1978;Biometrics Research, New York State Psychiatric Institute, New York.
9. Everitt B.S. Analysis of longitudinal data. Beyond MANOVA. Br. J. Psychiatry. 172:1998;7-10.
10. Golstein H. Multilevel Models in Educational and Social Research. 1987;Griffin, London.
11. Guy W. Assessment Manual for Psychopharmacology. 1976;National Institute of Mental Health, Early Clinical Drug Evaluation Unit.
12. Haas G.K., Sweeney J.A. Premorbid and onset features of first-episode schizophrenia. Schizophr. Bull. 18:1992;373-386.
13. Häfner H., an der Heiden W., Behrens S., Gattaz W.F., Hambrecht M., Löffler W., Maurer K., Munk-Jørgensen P., Nowotny B., Riechler-Rössler A., Stein A. Causes and consequences of the gender differences in age at onset of schizophrenia. Schizophr. Bull. 24:1998;99-113.
14. Heinrichs D.W., Hanlon T.E., Carpenter W.T. The quality of life scale: an instrument for rating the schizophrenic deficit syndrome. Schizophr. Bull. 10:1984;388-398.
15. Kay S.R., Fizbein A., Opler L.A. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr. Bull. 13:1987;261-276.
16. Kendler S.K., Prescott C.A. A population-based twin study of lifetime major depression in men and women. Arch. Gen. Psychiatry. 56:1999;39-44.
17. Lecrubier Y., Seehan D.V., Weiller E., Amorin P., Bonora I., Seehan K.H., Janavs J., Dunbar G.C. The Mini International Neuropsychiatric Interview (MINI). A short diagnostic structured interview: reliability and validity according to the CIDI. Eur. Psychiatry. 12:1997;224-231.
18. Loebel A.D., Lieberman J.A., Alvir J.M, Mayerhoff D.I., Geisler S.H., Szymanski S.R. Duration of psychosis and outcome in first-episode schizophrenia. Am. J. Psychiatry. 149:1992;1183-1188.
19. McGlashan T.H. Duration of untreated psychosis in first-episode schizophrenia: marker or determinant of course? Biol. Psychiatry. 46:1999;899-907.
20. McGlashan T.H., Johannessen J.O. Early detection and intervention with schizophrenia: rationale. Schizophr. Bull. 22:1996;201-222.
21. McGorry P.D., Edwards J., Mihalopoulos C., Harrigan S.M., Jackson H.J. EPPIC: an evolving system of early detection and optimal management. Schizophr. Bull. 22:1996;305-326.
22. Navarro F., van Os J., Jones P., Murray R.M. Explaining sex differences in outcome in the functional psychoses. Schizophr. Res. 21:1996;161-170.
23. STATA Statistical Software: Release 6. 1999;STATA Corporation, College Station, TX.
24. van Os J., Fahy T.A., Jones P., Harvey I., Sham P., Lewis S., Bebbington P., Toone B., Williams M., Murray R.M. Psychopathological syndromes in the functional psychoses. Associations with course and outcome. Psychol. Med. 26:1995;161-176.
25. van Os J., Jones P., Sham P., Bebbington P., Murray R.M. Risk factors for onset and persistence of psychosis. Soc. Psychiatry Psychiatr. Epidemiol. 33:1998;596-605.
26. van Os J., Gilvarry C., Bale R., van Horn E., Tattan T., Whiter I., Murray R. To what extent does symptomatic improvement result in better outcome in psychotic illness? Psychol. Med. 29:1999;1183-1195.
27. Verdoux H., Bergey C., Assens F., Abalan F., Gonzales B., Pauillac P., Fournet O., Liraud F., Beaussier J.P., Gaussares C., Etchegaray B., van Os J. Prediction of duration of psychosis before first admission. Eur. Psychiatry. 13:1998;346-352.
28. Verdoux H., Liraud F., Gonzales B., Assens F., Abalan F., Beaussier J.P., Gaussares C., Etchegaray B., van Os J. Associations between neuropsychological performances and clinical variables in first-admitted subjects with psychotic disorders. Schizophr. Res. 37:1999;197-203.
29. Verdoux H., Liraud F., Gonzales B., Assens F., Abalan F., van Os J. Suicidality and substance misuse in first-admitted subjects with psychotic disorder. Acta Psychiatr. Scand. 100:1999;389-395.
30. Waddington J.L., Youssef H.A., Kinsella A. Sequential cross-sectional and 10-years prospective study of severe negative symptoms in relation to duration of initially untreated psychosis in chronic schizophrenia. Psychol. Med. 25:1995;849-857.
31. WHO coordinated multi-center study on the course and outcome of schizophrenia. 1992;World Health Organization, Geneva.
32. Wyatt R.J., Green M.F., Tuma A.H. Long-term morbidity associated with delayed treatment of first admission schizophrenic patients: a re-analysis of the Camarillo State Hospital data. Psychol. Med. 27:1997;261-268.